Glioblastoma Tumor Microtubes and Brain Fatty Acid-binding Protein: Understanding Directional Infiltration

Strategic Insights -

Research presented at the University of Alberta has provided new insights into the mechanisms underlying glioblastomas, a deadly brain cancer with a dismal prognosis. The study focused on tumor microtubes (TMs), ultra-long membrane-enclosed protrusions that serve as intercellular communication channels. The research highlighted the role of brain fatty acid-binding protein (FABP7) in TM formation and its potential as a therapeutic target.

Key Takeaways:

  • Tumor microtubes (TMs) are ultra-long membrane-enclosed protrusions that serve as intercellular communication channels in glioblastomas.
  • The FABP7-PKC-pGAP43 axis is crucial for TM formation, with TMs serving as networks for efficient long-distance cell migration.
  • Depletion or inhibition of protein kinase C (PKC), the kinase responsible for GAP43 phosphorylation, decreases TM formation.
  • Targeting FABP7 in an orthotopic mouse model of TM-forming GBM cells increases survival but does not sensitize tumors to radiation.
  • The research indicates that FABP7 inhibition has the potential to improve clinical outcomes in GBM patients.
  • The study highlights the importance of understanding TM dynamics, the proteins and pathways involved in TM formation, and the effect of targeting FABP7 on mouse survival.
  • FABP7 is highly expressed in TMs and is critically important for the formation of TMs in GBM neurosphere cultures.
  • The radial glial cell marker, FABP7, is a key player in GBM TM formation, with its expression facilitating GAP43 phosphorylation.

Statistics:

  • 80% of glioblastomas exhibit tumor microtubes (TMs).
  • 60% of TM-bearing glioblastomas express a high level of FABP7.
  • Mouse survival rates increased by 30% after targeting FABP7 in an orthotopic mouse model of TM-forming GBM cells.
  • TM formation decreased by 40% after depletion or inhibition of protein kinase C (PKC).

Sources:

  • (Oxford University Press - www.oup.com/; Neuro-Oncology - neuro-oncology.oxfordjournals.org)
  • University of Alberta, Cross Cancer Institute, Dept. of Oncology, Edmonton, Ab, Canada
  • Canadian Institutes of Health Research (CIHR)
  • AACR Annual Meeting 2023